Business

Science to Consumers Inc. Signs Exclusive License Agreement With Biomatrix, Inc.

Science to Consumers Inc. Signs Exclusive License Agreement With Biomatrix, Inc..

articleScience To Consumers IncFebruary 22, 20165/company/science-to-consumers-inc/news/science-to-consumers-inc-signs-exclusive-license-agreement-with-biomatrix-inc
Science to Consumers Inc. Signs Exclusive License Agreement With Biomatrix, Inc.

About this update from Science To Consumers Inc

[{"type":"text","content":"\n \n \n Science to Consumers Inc. Signs Exclusive License Agreement With Biomatrix, Inc.\n \n \nScience to Consumers Inc. Signs Exclusive License Agreement With Biomatrix, Inc.\n \n GUANGZHOU, CHINA--(Marketwired - Feb 22, 2016) - Science to Consumers Inc. (OTCQB: BEUT) (The Company) is pleased to announce that on December 29, 2015 the Company signed a five-year exclusive licensing agreement with Biomatrix, Inc. for the People's Republic of China and Europe.\n Science to Consumers, Inc., is focused on anti-aging and good-for-your-body products. Utilizing 21st century science and cost-effective high-return marketing, the Company is poised to take advantage of the aging of the largest single demographic group in history, the baby boomers.\n The agreement will allow Science to Consumers Inc., to market and sell at least six of its special formulated anti-aging products including the DermaLastyl line. The first products the Company plans to sell are DermaLastyl skin care products. DermaLastyl is a trademarked anti-aging cream that helps to reduce wrinkles through the use of revolutionary science. The key ingredient, Tropoelastin, is a patented formulation of elastin produced by genetic engineering that promotes healing and renewing of the skin.\n Protein Genomics, Inc., based in Flagstaff, Arizona, created Tropoelastin specifically to heal wounds. The Company, now through its agreement with Biomatrix, Inc., has the exclusive license and rights to market Tropoelastin for cosmetic applications in the markets of China and Europe.\n The patented science and IP technology licensed to the Company provides an advantage over the competition because DermaLastyl actually repairs and heals damaged elastin, thus reversing the appearance of aging.\n The DermaLastyl line are genetically engineered products on the market that helps restore elastin and elastic properties to the skin and around the eyes.\n \"Science to Consumers and Biomatrix Inc. have worked diligently over the past year to finalize this agreement and we are ecstatic to implement these ground-breaking products to the Chinese and European markets. Anti-aging products represent a multi-billion-dollar industry and I am confident with our marketing and e-commerce expertise we will have unlimited opportunities to service this growing market,\" stated Edwon Lam, the Chief Executive Offi...

More updates from Science To Consumers Inc